X T L Biopharmaceuticals logo

X T L Biopharmaceuticals Share Price Today

(NASDAQ: XTLB)

X T L Biopharmaceuticals share price is $1.35 & ₹117.41 as on 6 Mar 2025, 2.30 'hrs' IST

$1.35

-0.03

(-2.05%)

Market is closed - opens 8 PM, 06 Mar 2025

View live X T L Biopharmaceuticals share price in Dollar and Rupees. Guide to invest in X T L Biopharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in X T L Biopharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

X T L Biopharmaceuticals share price movements

  • Today's Low: $1.32
    Today's High: $1.37

    Day's Volatility :3.64%

  • 52 Weeks Low: $0.85
    52 Weeks High: $4.99

    52 Weeks Volatility :82.96%

X T L Biopharmaceuticals (XTLB) Returns

PeriodX T L Biopharmaceuticals LtdIndex (Russel 2000)
3 Months
-30.29%
0.0%
6 Months
-49.14%
0.0%
1 Year
50.98%
0.0%
3 Years
-40.03%
-11.6%

X T L Biopharmaceuticals (XTLB) Key Statistics

in dollars & INR

Previous Close
$1.3732
Open
$1.37
Today's High
$1.37
Today's Low
$1.3201
Market Capitalization
$12.4M
Today's Volume
$19.2K
52 Week High
$4.9897
52 Week Low
$0.85
Revenue TTM
$46.0K
EBITDA
$-764.0K
Earnings Per Share (EPS)
$-0.2
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.76%
Return On Equity TTM
-25.7%

How to invest in X T L Biopharmaceuticals Stock (XTLB) from India?

It is very easy for Indian residents to invest directly in X T L Biopharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the X T L Biopharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for X T L Biopharmaceuticals or XTLB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of X T L Biopharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of X T L Biopharmaceuticals shares which would translate to 0.644 fractional shares of X T L Biopharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like X T L Biopharmaceuticals, in just a few clicks!

Returns in X T L Biopharmaceuticals (XTLB) for Indian investors in Rupees

The X T L Biopharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

X T L Biopharmaceuticals investment value today

Current value as on today

₹1,53,314

Returns

₹53,314

(+53.31%)

Returns from X T L Biopharmaceuticals Stock

₹48,352 (+48.35%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards X T L Biopharmaceuticals (XTLB)

-63%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for X T L Biopharmaceuticals Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in X T L Biopharmaceuticals

  • Noked Israel Ltd

    2.26%

  • Morgan Stanley - Brokerage Accounts

    0.21%

  • Rhumbline Advisers

    0.12%

Analyst Recommendation on X T L Biopharmaceuticals

Analyst Forecast on X T L Biopharmaceuticals Stock (XTLB)

What analysts predicted

Upside of 2122.22%

Target:

$30.00

Current:

$1.35

Insights on X T L Biopharmaceuticals Stock (Ticker Symbol: XTLB)

  • Price Movement

    In the last 7 days, XTLB stock has moved up by 4.8%
  • XTLB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 11.4%
  • XTLB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 90.2%

X T L Biopharmaceuticals Technicals Summary

Sell

Neutral

Buy

X T L Biopharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

X T L Biopharmaceuticals (XTLB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
X T L Biopharmaceuticals Ltd logo
-19.22%
-49.14%
50.98%
-40.03%
7.28%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
X T L Biopharmaceuticals Ltd logo
NA
NA
0.0
0.0
-0.26
-0.16
NA
0.01
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
X T L Biopharmaceuticals Ltd logo
NA
$12.4M
7.28%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About X T L Biopharmaceuticals

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
Organization
X T L Biopharmaceuticals
Employees
0
CEO
Mr. Shlomo Spokone Shalev
Industry
Health Technology

Management People of X T L Biopharmaceuticals

NameTitle
Mr. Shlomo Spokone Shalev
CEO & Director
Mr. Itay Weinstein CPA
Chief Financial Officer

Important FAQs about investing in XTLB Stock from India :

What is X T L Biopharmaceuticals share price today?

X T L Biopharmaceuticals share price today stands at $1.35, Open: $1.37 ; Previous Close: $1.37 ; High: $1.37 ; Low: $1.32 ; 52 Week High: $4.99 ; 52 Week Low: $0.85.

The stock opens at $1.37, after a previous close of $1.37. The stock reached a daily high of $1.37 and a low of $1.32, with a 52-week high of $4.99 and a 52-week low of $0.85.

Can Indians buy X T L Biopharmaceuticals shares?

Yes, Indians can invest in the X T L Biopharmaceuticals (XTLB) from India.

With INDmoney, you can buy X T L Biopharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy X T L Biopharmaceuticals at zero transaction cost.

How can I buy X T L Biopharmaceuticals shares from India?

It is very easy to buy X T L Biopharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of X T L Biopharmaceuticals (XTLB) be purchased?

Yes, you can buy fractional shares of X T L Biopharmaceuticals with INDmoney app.

What are the documents required to start investing in X T L Biopharmaceuticals stocks?

To start investing in X T L Biopharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of X T L Biopharmaceuticals Stock (XTLB)?

Today’s highest price of X T L Biopharmaceuticals (XTLB) is $1.37.

Today’s lowest price of X T L Biopharmaceuticals (XTLB) is $1.32.

What is today's market capitalisation of X T L Biopharmaceuticals?

Today's market capitalisation of X T L Biopharmaceuticals XTLB is 12.4M

What is the 52 Week High and Low Range of X T L Biopharmaceuticals Stock (XTLB)?

  • 52 Week High

    $4.99

  • 52 Week Low

    $0.85

What are the historical returns of X T L Biopharmaceuticals (XTLB)?

  • 1 Month Returns

    -19.22%

  • 3 Months Returns

    -49.14%

  • 1 Year Returns

    50.98%

  • 5 Years Returns

    7.28%

Who is the Chief Executive Officer (CEO) of X T L Biopharmaceuticals ?

Mr. Shlomo Spokone Shalev is the current Chief Executive Officer (CEO) of X T L Biopharmaceuticals.